ATE482973T1 - Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper - Google Patents

Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper

Info

Publication number
ATE482973T1
ATE482973T1 AT04719660T AT04719660T ATE482973T1 AT E482973 T1 ATE482973 T1 AT E482973T1 AT 04719660 T AT04719660 T AT 04719660T AT 04719660 T AT04719660 T AT 04719660T AT E482973 T1 ATE482973 T1 AT E482973T1
Authority
AT
Austria
Prior art keywords
peptide fragment
lyve
directed against
antibody directed
amino acid
Prior art date
Application number
AT04719660T
Other languages
English (en)
Inventor
Kinji Ito
Toshiharu Ishii
Yuri Fukasawa
Original Assignee
Oriental Yeast Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oriental Yeast Co Ltd filed Critical Oriental Yeast Co Ltd
Application granted granted Critical
Publication of ATE482973T1 publication Critical patent/ATE482973T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04719660T 2003-03-14 2004-03-11 Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper ATE482973T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003070568 2003-03-14
PCT/JP2004/003231 WO2004081035A1 (ja) 2003-03-14 2004-03-11 Ｌｙｖｅ－１のペプチドフラグメント及びそれに対する抗体

Publications (1)

Publication Number Publication Date
ATE482973T1 true ATE482973T1 (de) 2010-10-15

Family

ID=32984660

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04719660T ATE482973T1 (de) 2003-03-14 2004-03-11 Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper

Country Status (11)

Country Link
US (2) US7339022B2 (de)
EP (1) EP1614690B1 (de)
JP (1) JP3899362B2 (de)
KR (1) KR20050108390A (de)
CN (1) CN1761679A (de)
AT (1) ATE482973T1 (de)
AU (1) AU2004220209A1 (de)
CA (1) CA2518548C (de)
DE (1) DE602004029345D1 (de)
DK (1) DK1614690T3 (de)
WO (1) WO2004081035A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4851620B2 (ja) * 2008-04-11 2012-01-11 有限会社スリーピー Ｎｋ４に対するモノクローナル抗体
GB201901559D0 (en) 2019-02-05 2019-03-27 Syngenta Crop Protection Ag Herbicidal compositions
CN115531558B (zh) * 2022-09-16 2024-07-26 华中科技大学 一种动物肝脏淋巴管系统的标记和三维图谱成像方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5231000A (en) * 1987-10-08 1993-07-27 The Mclean Hospital Antibodies to A4 amyloid peptide
AU6721696A (en) * 1996-07-15 1998-03-06 Human Genome Sciences, Inc. Cd44-like protein
US7160985B2 (en) 1997-10-29 2007-01-09 Genentech, Inc. Pro180 polypeptide
US6368794B1 (en) * 1999-01-15 2002-04-09 Incyte Genomics, Inc. Detection of altered expression of genes regulating cell proliferation
US20040018594A1 (en) * 2001-05-03 2004-01-29 Alsobrook John P. Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
CN1555488A (zh) 2001-07-12 2004-12-15 路德维格癌症研究院 淋巴管内皮细胞物质及方法

Also Published As

Publication number Publication date
CA2518548A1 (en) 2004-09-23
US20090053202A1 (en) 2009-02-26
US7858751B2 (en) 2010-12-28
WO2004081035A1 (ja) 2004-09-23
JPWO2004081035A1 (ja) 2006-08-24
AU2004220209A1 (en) 2004-09-23
CA2518548C (en) 2011-12-06
CN1761679A (zh) 2006-04-19
DK1614690T3 (da) 2010-12-20
US20060127396A1 (en) 2006-06-15
DE602004029345D1 (de) 2010-11-11
EP1614690A1 (de) 2006-01-11
EP1614690B1 (de) 2010-09-29
KR20050108390A (ko) 2005-11-16
JP3899362B2 (ja) 2007-03-28
US7339022B2 (en) 2008-03-04
EP1614690A4 (de) 2006-07-26

Similar Documents

Publication Publication Date Title
ATE387629T1 (de) Gemeinsame epitope von antigenen aus einer multigen-familie
DE112006000677A5 (de) Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form
DE60232577D1 (de) Oligomerische komplexe von chimären proteinen mit verbessertem immunogenen potential
NO20063026L (no) Antistoffer
CY1118037T1 (el) Αντισωματα εναντι του αβητα και h χρηση τους
ES2676023T3 (es) Polipéptidos de IL-22 y proteínas de fusión de IL-22 Fc y métodos de uso
EA200700973A1 (ru) Слитый белок, содержащий домен bh3 белка «вh3-только»
WO2002018443A3 (en) A recombinant monoclonal antibody to phosphotyrosine-containing proteins
DE60335726D1 (de) Chromoprotein und fluoroproteine
NZ547629A (en) Antibodies binding to conformationally discriminating epitopes of human IGG Fc receptor IIb and IIb
BRPI0715331B8 (pt) polipeptídeo que compreende uma porção n-terminal e uma porção c-terminal, e uso do mesmo
DE602004029345D1 (de) Peptidfragment von lyve-1 und gegen dieses gerichteter antikörper
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
DK1368372T3 (da) Peptid med affinitet til det virale gp120-protein samt anvendelse deraf
DK1519951T3 (da) Kationiske ligekædede peptider med antifungale egenskaber
WO2006075253A3 (en) Peptides for desensitizing subjects allergic to dog hair and dander and compositions containing said peptides.
DK1448772T3 (da) Fremgangsmåder til forögelse af ekspressionsniveauer af human TNF-receptor
JP2005535281A5 (de)
DK1913020T3 (da) Immunogene konstrukter
WO2001057215A3 (en) Human g-protein coupled receptor polypeptides and polynucleotides having homology with odorant receptors
WO2004056316A3 (en) Vaccines against hiv-1 tat protein to generate neutralizing antibodies
SE0101519D0 (sv) Nucleic ACID
DE602005016417D1 (de) Neue polypeptide zur in-vintro-isolierung und vorbeugung von infektionen mit legionella pneumophila
DE60330256D1 (de) Bakteriophagen-vermittelte immunisierung gegen hepatitis
ATE511516T1 (de) Gpr-146-rezeptor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties